FDA’s New Rules for CRAS Provide Clarity on what is Safe Food

This week FDA announced the final rule for determining the “Generally Recognized as Safe” (GRAS) status of food ingredients. The new process replaces the current process of petitioning FDA to affirm the GRAS status, with a voluntary notification about a conclusion that a substance is GRAS under the conditions of its intended use in human food or … Read more

New RFD Process: FDA’s Tacit Acknowledgment of Flaws in the System

It is critical that a product be properly classified as a drug or medical device. For products where a clear unambiguous scientifically justifiable classification as a drug or medical device cannot be made, the developer are required to make a Request for Designation (RFD) with the Office of Combination Products (OCP) at the FDA. Classification of a given product … Read more

Spiderman is Real! Well.. May be Soon

Not really, but we might be going down the road to create one with NIH funding. This week, NIH lifted a moratorium on insertion of human stem cells into early stage embryos of non-human vertebrate animals to create human-animal chimera. This represents a unique balance of scientific curiosity, medical benefit, and ethical dilemma. Human-animal chimeras have dominated … Read more

Want to Make Wearable Devices More Appealing? Register with FDA

This week Philips Healthcare announced release of a smart watch very similar in functionality and appearance to Fitbit, Apple’s iWatch or Samsung Gear watch. However, the Philips watch has one difference from its competition; it is registered with the FDA as a medical device. Smart watches are not considered medical devices by FDA and do not require registration or … Read more

Email Leaks, Politics and FDA-Regulated Industry

An email leak from a Democratic National Committee (DNC) led to the Chair of the DNC losing her job and the leader of the party barely surviving a major crisis on the eve of the convention. This followed concerns of security of personal and official emails. This episode highlights once again the high-risk of electronic … Read more

Manufacturers of Biologics to Increasingly Use Single-Use Technologies

Biologics manufacturing facilities using traditional stainless-steel bioreactors have to deal with significant manufacturing suite unavailability between production cycles due to expensive cleaning technology, extensive cleaning validation, and the associated loss of productivity and revenue. The use of single-use and disposal technologies such as single-use bioreactors (SUB) can greatly increase the production efficiency by reducing the … Read more